Ignite Creation Date:
2024-05-06 @ 4:21 PM
Last Modification Date:
2024-10-26 @ 2:09 PM
Study NCT ID:
NCT04968964
Status:
RECRUITING
Last Update Posted:
2024-06-06
First Post:
2021-07-08
Brief Title:
Treatment Monitoring of Patients Receiving CDK 46 Inhibitors for Hormone Receptor HR Positive HER2 Negative Metastatic Breast Cancer MBC With or Without the Addition of DiviTum Serum Thymidine Kinase 1 TK1 Activity Testing
Sponsor:
Washington University School of Medicine
Organization:
Washington University School of Medicine
Organization Data
Organization:
Washington University School of Medicine
Class:
OTHER
Study ID:
202107015
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Washington University School of Medicine
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Biovica | UNKNOWN |